An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.87.2.705PMID 1689049PMCID PMC53334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells.

  1989cited by this paper
• Human testis cDNA for the regulatory subunit RIIα of CAMP‐dependent protein kinase encodes an alternate amino‐terminal region

  1989cited by this paper
• Site-selective 8-chloro-cyclic adenosine 3',5'-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms.

  1989cited by this paper
• Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase.

  1988cited by this paper
• Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin.

  1988cited by this paper
• Oligodeoxynucleotides as inhibitors of gene expression: a review.

  1988cited by this paper
• Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth.

  1988cited by this paper
• Techniques for using antisense oligodeoxyribonucleotides to study gene expression.

  1988cited by this paper
• Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?

  1988cited by this paper
• A unique mRNA species for a regulatory subunit of cAMP‐dependent protein kinase is specifically induced in haploid germ cells

  1988cited by this paper
• Reverse transformation of Harvey murine sarcoma virus-transformed NIH/3T3 cells by site-selective cyclic AMP analogs.

  1988cited by this paper
• Molecular cloning, complementary deoxyribonucleic acid structure and predicted full-length amino acid sequence of the hormone-inducible regulatory subunit of 3'-5'-cyclic adenosine monophosphate-dependent protein kinase from human testis.

  1988cited by this paper
• Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines.

  1988cited by this paper
• An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation

  1988cited by this paper
• The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain.

  1987cited by this paper
• A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

  1987cited by this paper
• Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene

  1987cited by this paper
• Molecular cloning, cDNA structure and deduced amino acid sequence for a type I regulatory subunit of cAMP-dependent protein kinase from human testis.

  1987cited by this paper
• Site‐selective cyclic AMP analogs provide a new approach in the control of cancer cell growth

  1987cited by this paper
• Genetic regulation of growth control: Role of cyclic AMP and cell cytoskeleton

  1987cited by this paper
• Cell differentiation and bypassing of genetic defects in the suppression of malignancy.

  1987cited by this paper
• A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase.

  1986cited by this paper
• Molecular cloning, cDNA structure, and regulation of the regulatory subunit of type II cAMP-dependent protein kinase from rat ovarian granulosa cells.

  1986cited by this paper
• Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase.

  1986cited by this paper
• Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.

  1986cited by this paper
• Clonal variants of PC12 pheochromocytoma cells with defects in cAMP-dependent protein kinases induce ornithine decarboxylase in response to nerve growth factor but not to adenosine agonists

  1985cited by this paper
• Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations.

  1985cited by this paper
• The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes.

  1985cited by this paper
• Probable involvement of both intrachain cAMP binding sites in activation of protein kinase.

  1983cited by this paper
• Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase.

  1983cited by this paper
• Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.

  1980cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Photoaffinity labeling of a protein kinase from bovine brain with 8-azidoadenosine 3',5'-monophosphate.

  1975cited by this paper
• DIFFERENTIATION OF NEUROBLASTOMA CELLS IN CULTURE

  1975cited by this paper
• Comparison of adenosine 3':5'-monophosphate-dependent protein kinases from rabbit skeletal and bovine heart muscle.

  1975cited by this paper
• The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

  1975cited by this paper
• Cyclic nucleotides in cultured cells.

  1975cited by this paper
• Role of cyclic nucleotides in growth control.

  1975cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• 8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth

  2017cites this paper
• PKA regulatory subunit R2B is required for murine and human adipocyte differentiation

  2013cites this paper
• PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group

  2012cites this paper
• Cyclic nucleotides and phosphodiesterases in monocytic differentiation.

  2011cites this paper
• Cancer Therapy : Preclinical Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines

  2009cites this paper
• Involvement of AMP‐activated protein kinase and p38 mitogen‐activated protein kinase in 8‐Cl‐cAMP‐induced growth inhibition

  2009cites this paper
• Protein Kinase A Regulatory Subunits in Human Adipose Tissue

  2009cites this paper
• Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines

  2009cites this paper
• High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

  2008cites this paper
• PKA Regulatory Subunits in Human Adipose Tissue : Decreased R 2 B Expression and Activity in Adipocytes from Obese Subjects

  2008cites this paper
• Chloroadenosine Mediates 8-Chloro-Cyclic AMP-induced Down-Regulation of Cyclic AMP-dependent Protein Kinase in Normal and Neoplastic Mouse Lung Epithelial Cells by a Cyclic AMP-independent ~ echanism '

  2007cites this paper
• Regulation of rat alveolar type 2 cell proliferation in vitro involves type II cAMP-dependent protein kinase.

  2007cites this paper
• Isolation and Characterization of an Apoptosis-resistant Variant of Human Leukemia HL-60 Cells That Has Switched Expression from Bcl-2 to Bcl-X^1

  2006cites this paper
• Significance of Protein Kinase A in Cancer

  2006cites this paper
• Inhibition in Human Cancer Cells of Cyclic AMP-dependent Protein Kinase Induces Growth Subunit α An Antisense Oligodeoxynucleotide That Depletes

  2006cites this paper
• Chemoprevention with Protein Kinase A RIα Antisense in DMBA‐Mammary Carcinogenesis

  2005cites this paper
• Tumor Reversion: Protein Kinase A Isozyme Switching

  2005cites this paper
• 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.

  2005cites this paper
• Killing the messenger: antisense DNA and siRNA.

  2004cites this paper
• Proliferation of Transformed Somatotroph Cells Related to Low or Absent Expression of Protein Kinase A Regulatory Subunit 1A Protein

  2004cites this paper
• Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.

  2004cites this paper
• Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray.

  2004cites this paper
• Antisense Protein Kinase A-RIα Restores Normal Signal Transduction Signatures to Inhibit Tumor Growth

  2004cites this paper
• 8‐Cl‐cAMP and its metabolite, 8‐Cl‐adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: Protein kinase C activation and cyclin B down‐regulation

  2004cites this paper
• Antisense protein kinase A RIα-induced tumor reversion: portrait of a microarray

  2004cites this paper
• cAMP signaling in cancer genesis and treatment.

  2003cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2003cites this paper
• Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.

  2002cites this paper
• Dissecting the Circuitry of Protein Kinase A and cAMP Signaling in Cancer Genesis

  2002cites this paper
• Phorbol Ester-Induced Actin Assembly in Neutrophils : Role ofProtein Kinase C

  2002cites this paper
• Cyclic AMP-dependent protein kinase isoenzymes in human myeloid leukemia (HL60) and breast tumor (MCF-7) cells.

  2001cites this paper
• 8‐Cl‐cAMP induces cell cycle‐specific apoptosis in human cancer cells

  2001cites this paper
• Oligonucleotide Sequence-Specific Inhibition of Gene Expression, Tumor Growth Inhibition, and Modulation of cAMP Signaling by an RNA-DNA Hybrid Antisense Targeted to Protein Kinase A RIα Subunit

  2000influential citation
• Participation of type II protein kinase A in the retinoic acid‐induced growth inhibition of SH‐SY5Y human neuroblastoma cells

  2000cites this paper
• A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.

  2000cites this paper
• Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.

  2000cites this paper
• The 3rd Annual NIH Symposium on Therapeutic Oligonucleotides. Bethesda, Maryland, USA. December 4, 1998. Abstracts.

  1999cites this paper
• α Regulatory Subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth

  1999cites this paper
• Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.

  1999cites this paper
• Abstracts from the Third Annual NIH Symposium on Therapeutic Oligonucleotides

  1999cites this paper
• Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment.

  1999influential citation
• Cyclic adenosine 3':5'-monophosphate-dependent protein kinase on the external surface of LS-174T human colon carcinoma cells.

  1999cites this paper
• Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatment.

  1999cites this paper
• Ala99ser mutation in RIα Regulatory Subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth

  1999cites this paper
• Rational enzyme-directed prodrug development : exploiting tumour hypoxia to target the bioactivation of cytotoxic prodrugs

  1998cites this paper
• The RIIbeta regulatory subunit of protein kinase A binds to cAMP response element: an alternative cAMP signaling pathway.

  1998cites this paper
• Nucleolus contains signal molecules that constitute membrane-nucleolus linked pathway

  1998cites this paper
• 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.

  1998cites this paper
• Subcellular distribution of the R‐subunits of cAMP‐dependent protein kinase in LS‐174T human colon carcinoma cells

  1998cites this paper
• The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-Receptor

  1997cites this paper
• Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL.

  1997cites this paper
• Growth inhibition of human ovarian cancer cells by differential modulation of protein Kinase a Isozymes

  1997cites this paper
• Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.

  1997cites this paper
• Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.

  1997cites this paper
• Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.

  1997cites this paper
• Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from Bcl-2 to Bcl-xL.

  1996cites this paper
• Overexpresson of RIIβ, Regulatory Subunit of Protein Kinase A in Human Colon Carcinoma Cell Induces Growth Arrest and Phenotypic Changes that are Abolished by Site‐Directed Mutation of RIIβ

  1996cites this paper
• Antisense oligonucleotide therapeutics: drug delivery and targeting

  1996cites this paper
• Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta.

  1996cites this paper
• Protein Kinase A-Directed Antisense Restrains Cancer Growth: Sequence-Specific Inhibition of Gene Expression

  1996influential citation
• Novel growth inhibitory effect of 8-Cl-cAMP is dependent on serum factors that modulate protein kinase A expression but not the hydrolysis of 8-Cl-cAMP.

  1996cites this paper
• Antisense regulation of oncogenes in human cancer.

  1996cites this paper
• Protein Kinase A Type I-directed Antisense Inhibition of Cancer Growth

  1996cites this paper
• Overexpression of RII beta regulatory subunit of protein kinase A induces growth inhibition and reverse-transformation in SK-N-SH human neuroblastoma cells.

  1996cites this paper
• Antisense oligodeoxynucleotides as clinical therapeutic agents.

  1996cites this paper
• Cyclic adenosine monophosphate‐dependent mechanisms induce von Willebrand factor expression in the Dami megakaryoblastic cell line

  1995cites this paper
• cAMP-dependent protein kinase: role in normal and malignant growth.

  1995cites this paper
• Multiple facets of the modulation of growth by cAMP.

  1995cites this paper
• Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts.

  1995cites this paper
• Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymes.

  1995cites this paper
• All-trans retinoic acid and cyclic adenosine monophosphate cooperate in the expression of leukocyte alkaline phosphatase in acute promyelocytic leukemia cells.

  1995cites this paper
• Induction of differentiation of HL-60 cells by the anti-fungal antibiotic, radicicol.

  1995cites this paper
• A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth

  1995cites this paper
• [Applications of antisense oligonucleotides in oncology].

  1994cites this paper
• Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts.

  1994cites this paper
• Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancers.

  1994cites this paper
• Differential effects of protein kinase a sub‐units on chinese‐hamster‐ovary cell cycle and proliferation

  1994cites this paper
• Applications of antisense oligonucleotides in oncology.

  1994cites this paper
• The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases.

  1993cites this paper
• Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.

  1993cites this paper
• A specific antisense oligodeoxynucleotide to mRNAs encoding receptors with seven transmembrane spanning regions decreases muscarinic m2 and gamma-aminobutyric acidB receptors in rat cerebellar granule cells.

  1993cites this paper
• Differentiation therapy of cancer targeting the ri-alpha regulatory subunit of cAMP-dependent protein-kinase (review).

  1993cites this paper
• Overview: Oncologic, Endocrine & Metabolic Antisense oligonucleotides for the treatment of cancer

  1993cites this paper
• The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.

  1993cites this paper
• Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.

  1993cites this paper
• The Regulatory Subunit of cAMP-Dependent Protein Kinase as a Target for Cancer Diagnosis and Therapy

  1993cites this paper
• 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.

  1993cites this paper
• 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells.

  1993cites this paper
• Novel marine alkaloids from the tunicate Eudistoma sp. are potent regulators of cellular growth and differentiation and affect cAMP‐mediated processes

  1993cites this paper
• Molecular Oncology and Clinical Applications

  1993cites this paper
• An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.

  1993cites this paper
• Therapeutic Applications of Oligonucleotides

  1992cites this paper
• Investigations into the structure-activity relationships of the luteinizing hormone receptor using antisense oligodeoxynucleotides.

  1992cites this paper
• v-ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A.

  1992cites this paper
• Pharmacology of second messengers: a critical appraisal.

  1992cites this paper
• Therapeutic applications of oligonucleotides.

  1992cites this paper
• The dual role of the cAMP-dependent protein kinase C alpha subunit in T-cell receptor-triggered T-lymphocytes effector functions.

  1992cites this paper
• Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.

  1992cites this paper
• 8-Chloro-cyclic adenosine monophosphate, a novel cyclic AMP analog that inhibits human glioma cell growth in concentrations that do not induce differentiation.

  1992cites this paper
• Analysis of mutations in the Gs protein alpha subunit gene in human leukaemia.

  1992cites this paper